Lipid parameters vary depending on age and sex

16-10-2017 • Balder JW et al., J Clin Lipidol. 2017
Based on data of the large Dutch Lifelines cohort, reference values have been developed for lipid parameters. Read more

More adverse events with generic ARBs compared with branded ARBs

13-10-2017 • Leclerc J et al., Circ Cardiovasc Qual Outcomes 2017
The use of generic ARBs resulted in higher rates of hospitalizations and emergency room consultations, particularly in the first month and with candesartan. Read more

Diabetic patients at high CV risk benefit from intensive BP control

5-10-2017 • Buckley LF et al., Diabetes Care 2017
In a SPRINT-eligible ACCORD-BP population, a high-risk cohort of diabetic patients, intensive BP control at a goal of <120 mmHg, reduced CVD outcomes. Read more

Non-statin LDL-lowering drug plus statin protects against stroke in post-ACS patients

3-10-2017 • Bohula EA et al., Circulation 2017
In the IMPROVE-IT study, the addition of ezetimibe to simvastatin in stabilized post-ACS patients reduced the frequency of ischemic stroke, particularly in patients with a history of prior stroke. Read more

Benefit of physical activity to lower risk of mortality and CVD is seen worldwide

2-10-2017 • Lear SA et al. Lancet 2017
Physical activity is a low-cost approach to reduce deaths and CV disease that is applicable globally with a potential large impact. Read more

Obesity without metabolic abnormalities still associated with increased CV risk

25-9-2017 • Caleyachetty R et al., J Am Coll Cardiol 2017
Individuals previously considered “metabolically healthy obese” are still at higher CV risk compared with normal weight metabolically healthy persons, according to a large UK health record dataset. Read more
News • 16-10-2017

EPCCS Practical Guidance on Heart Failure Diagnosis and Management in Primary Care

Based on the Heart Failure session and discussion during the 8th EPCCS Annual Meeting in Prague, this guidance document was written to help physicians diagnose and manage heart failure in their primary care practice. Read more

More atherosclerosis seen in those who skip breakfast

9-10-2017 • Uzhova I et al., J Am Coll Cardiol 2017
Skipping breakfast was associated with a higher risk of non-coronary and generalized atherosclerosis in a sample of asymptomatic individuals in thee prospective PESA study. Read more
News • 4-10-2017

Meditation may help CV risk reduction, according to cautiously formulated AHA Scientific Statement

Based on current evidence – mostly of modest methodological quality – AHA concludes that meditation, given its low costs and low risk, may be an adjunct to conventional CV risk reduction approaches. Read more

Discontinuation of long-term aspirin use for CVD prevention associated with higher CV risk

3-10-2017 • Sundström J et al., Circulation. 2017
The discontinuation of low-dose long-term aspirin use for CVD prevention in the absence of major surgery or bleeding, was associated with a >30% increased CV risk, shortly after discontinuation. Read more

Suboptimal adherence to secondary prevention post-MI increases mortality

26-9-2017 • Korhonen MJ et al. J Am Coll Cardiol 2017
Post-AMI patients who are adherent to ACE inhibitors/ARBs and statins, but not to beta-blockers, had a similar mortality risk compared with those adherent to all 3 therapies. Read more
News • 19-9-2017

ESC GRAND DEBATE | Aspirin for life

ESC 2017 One of the ESC Grand Debates revolved around whether or not aspirin should be used for primary and/or secondary CV prevention. Yes, there is a lot of evidence, but how valid is that evidence? Read an impression of the debate. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...